Skip to main content

01011 · NT PHARMA · Debt

0.4100 HKD +0.0200 (+5.13%) At close · Sep 29
Market Cap
736.59M HKD
Shares
1.80B

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2025-12-31 CNY 487,000 Annual report filed 2026-04-30
Current other borrowings 2025-12-31 CNY 316,126,000 Annual report filed 2026-04-30
Noncurrent lease liabilities 2025-12-31 CNY 85,000 Annual report filed 2026-04-30
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.